Renal diseases stand as a significant health concern globally, ranking as the 10th leading cause of death and affecting approximately 10% of the world’s population, resulting in an alarming 1.3 million deaths annually as of 2019.
In the United States, 37 million adults grapple with Chronic Kidney Disease (CKD), with an estimated 90% of cases remaining undiagnosed and untreated. A multitude of factors contribute to kidney disease, including prevalent conditions such as Diabetes, Hypertension, Heart disease/failure, Acute Kidney Injury, Nephrotoxicity (often resulting from cancer treatments), Glomerular diseases, Severe infections such as sepsis, Inherited conditions, and various other etiologies.
Early detection and intervention play pivotal roles in halting or slowing the progression of kidney diseases. Monitoring renal function is typically conducted through the assessment of Glomerular Filtration Rate (GFR), serving as the primary marker for diagnosing, monitoring, and guiding treatment strategies for kidney ailments.
Currently estimating GFP using SrCr and/or Cystatic C. Problems, subject to nonGFR determinants, up to 48 hour delay in reflecting GFR changes
This product is manufactured in Germany by Nephrolyx.
| Storage | Room Temp |
| Alternative Names | Measured Glomular Filtration Rate, mGFR |